Global EditionASIA 中文双语Français
Home / China / Latest

China-developed nasal spray vaccine for COVID-19 approved for clinical trials

Xinhua | Updated: 2020-09-09 22:17
Share - WeChat

HONG KONG — The University of Hong Kong (HKU) Wednesday announced that the clinical trials of a nasal spray vaccine for COVID-19 jointly developed by the university's Department of Microbiology and mainland institutions have been approved.

The State Key Laboratory of Emerging Infectious Diseases has been working on the vaccine with Xiamen University and Beijing Wantai Biological Pharmacy.

It is the first nasal spray COVID-19 vaccine approved by the China's National Medical Products Administration for clinical trial in humans.

The HKU said in a statement that its vaccine strategy has been selected as one of the five vaccine technologies by the Ministry of Science and Technology for further evaluation.

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349